Abstract:Recruitment of neutrophils into and across the gut mucosa is a cardinal feature of intestinal inflammation in response to enteric infections. Previous work using the model pathogen Salmonella enterica serovar Typhimurium ( S .Tm) established that invasion of intestinal epithelial cells by S .Tm leads to recruitment of neutrophils into the gut lumen, where they can reduce pathogen loads transiently. Notably, a fraction of the pathogen population can survive this defense, re-grow to high density, and continue triggering enteropathy. However, the functions of intraluminal neutrophils in the defense against enteric pathogens and their effects on preventing or aggravating epithelial damage are still not fully understood. Here, we address this question via neutrophil depletion in different mouse models of Salmonella colitis, which differ in their degree of enteropathy. In an antibiotic pretreated mouse model, neutrophil depletion by an anti-Ly6G antibody exacerbated epithelial damage. This could be linked to compromised neutrophil-mediated elimination and reduced physical blocking of the gut-luminal S .Tm population, such that the pathogen density remained high near the epithelial surface throughout the infection. Control infections with a ssaV mutant and gentamycin-mediated elimination of gut-luminal pathogens further supported that neutrophils are protecting the luminal surface of the gut epithelium. Neutrophil depletion in germ-free and gnotobiotic mice hinted that the microbiota can modulate the infection kinetics and ameliorate epithelium-disruptive enteropathy even in the absence of neutrophil-protection. Together, our data indicate that the well-known protective effect of the microbiota is augmented by intraluminal neutrophils. After antibiotic-mediated microbiota disruption, neutrophils are central for maintaining epithelial barrier integrity during acute Salmonella -induced gut inflammation, by limiting the sustained pathogen assault on the epithelium in a critical window of the infection. Microbiota and mucosal immune system work in coordination to protect our intestine against enteric infections under homeostasis. Dysregulation of this defense increases the risk of inflammatory diseases. Infectious agents such as Salmonella enterica or Clostridium difficile trigger particular neutrophil responses, namely crypt abscesses or pseudomembranous colitis. These are characterized by pronounced neutrophil influx and aggregate formation in the gut lumen. However, if these neutrophils are protective or damage-inducing is not well understood. Here we use mouse models for Salmonella Typhimurium to study this question. We observed that luminal neutrophils constitute an important part of the coordinated immune response to Salmonella invasion of the gut epithelium. In the absence of neutrophils, the continuous pathogen attacks on the epithelial cells overwhelm the system and lead to elevated epithelial cell loss. We show that intraluminal defense is especially important if the microbiota is perturbed or missing. Infection of germ-free mice lacking neutrophil defense leads to the complete destruction of the epithelial layer. This work provides new insights into the protective role of microbiota and intraluminal neutrophils, and how they together ensure the maintenance of epithelial barrier integrity against enteric infections.

The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice

Suppression of IL-17 producing type 3 innate lymphoid cells and increased susceptibility to Klebsiella pneumoniae sepsis in neonatal mice exposed to extended empiric antibiotics

Klebsiella Michiganensis Transmission Enhances Resistance to Enterobacteriaceae Gut Invasion by Nutrition Competition

The Role of Microbiota in Neutrophil Regulation and Adaptation in Newborns

Priority order of neonatal colonization by a probiotic or pathogenic Escherichia coli strain dictates the host response to experimental colitis

Neonatal microbiota-epithelial interactions that impact infection

Changes in the microbiota in different intestinal segments of mice with sepsis

Arresting microbiome development limits immune system maturation and resistance to infection in mice

CD71 + erythroid cells promote intestinal symbiotic microbial communities in pregnancy and neonatal period

Neonatal microbiota colonization drives maturation of primary and secondary goblet cell mediated protection in the pre-weaning colon

The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis

Postnatal development of the small intestinal mucosa drives age-dependent, regio-selective susceptibility to Escherichia coli K1 infection

Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag-/- Mice

Priming of microvascular endothelium by microbiota-derived metabolites regulates neutrophil trafficking to the liver during sepsis

Early life microbiome influences on development of the mucosal innate immune system

Alterations in the Gut Microbiome and Cecal Metabolome During Klebsiella pneumoniae-Induced Pneumosepsis

Gut microbiota-reactive IgG regulates gut microbiota development and immunity against enteric pathogens in early life

Colonization of fecal microbiota from patients with neonatal necrotizing enterocolitis exacerbates intestinal injury in germfree mice subjected to necrotizing enterocolitis-induction protocol via alterations in butyrate and regulatory T cells

Intraluminal neutrophils limit epithelium damage by reducing pathogen assault on intestinal epithelial cells during Salmonella gut infection

Postnatal intestinal mucosa and gut microbial composition develop hand in hand: A mouse study

The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung is enforced by gut microbiota